HomeCompareORINY vs DVY

ORINY vs DVY: Dividend Comparison 2026

ORINY yields 2.66% · DVY yields 3.50%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DVY wins by $4.8K in total portfolio value
10 years
ORINY
ORINY
● Live price
2.66%
Share price
$37.99
Annual div
$1.01
5Y div CAGR
-45.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$0.66
Full ORINY calculator →
DVY
DVY
● Live price
3.50%
Share price
$150.03
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$437.78
Full DVY calculator →

Portfolio growth — ORINY vs DVY

📍 DVY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORINYDVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORINY + DVY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ORINY pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORINY
Annual income on $10K today (after 15% tax)
$226.00/yr
After 10yr DRIP, annual income (after tax)
$0.56/yr
DVY
Annual income on $10K today (after 15% tax)
$297.17/yr
After 10yr DRIP, annual income (after tax)
$372.11/yr
At 15% tax rate, DVY beats the other by $371.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORINY + DVY for your $10,000?

ORINY: 50%DVY: 50%
100% DVY50/50100% ORINY
Portfolio after 10yr
$22.6K
Annual income
$219.22/yr
Blended yield
0.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORINY right now

ORINY
Analyst Ratings
2
Buy
1
Hold
Consensus: Buy
Altman Z
18.6
Piotroski
6/9
DVY
No analyst data
Altman Z
307.5
Piotroski
1/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORINY buys
0
DVY buys
0
No recent congressional trades found for ORINY or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORINYDVY
Forward yield2.66%3.50%
Annual dividend / share$1.01$5.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-45.3%0%
Portfolio after 10y$20.2K$25.1K
Annual income after 10y$0.66$437.78
Total dividends collected$324.00$4.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ORINY vs DVY ($10,000, DRIP)

YearORINY PortfolioORINY Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$10,845$145.43$11,050$349.62$205.00DVY
2$11,685$80.63$12,184$361.04$499.00DVY
3$12,548$44.41$13,409$372.07$861.00DVY
4$13,450$24.38$14,730$382.68$1.3KDVY
5$14,405$13.36$16,154$392.89$1.7KDVY
6$15,421$7.31$17,688$402.69$2.3KDVY
7$16,504$4.00$19,338$412.07$2.8KDVY
8$17,662$2.19$21,113$421.04$3.5KDVY
9$18,899$1.20$23,020$429.61$4.1KDVY
10$20,223$0.66$25,070$437.78$4.8KDVY

ORINY vs DVY: Complete Analysis 2026

ORINYStock

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.

Full ORINY Calculator →

DVYETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this ORINY vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORINY vs SCHDORINY vs JEPIORINY vs OORINY vs KOORINY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.